11132103 |
Structural determinants within platelet glycoprotein Ibalpha involved in its binding to von Willebrand factor
Cauwenberghs, N,
Vauterin, S,
Vanhoorelbeke, K,
Deckmyn, H
|
Platelets |
2000 |
19114653 |
A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis
Groner, Y,
Pencovich, N,
Lotem, J,
Levanon, D,
Ben-Ami, O
|
Proc. Natl. Acad. Sci. U.S.A. |
2009 |
12588352 |
Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates
Jilma-Stohlawetz, P,
Unger, P,
Knechtelsdorfer, M,
Mannhalter, C,
Jilma, B,
Panzer, S,
Santoso, S,
Homoncik, M
|
Br. J. Haematol. |
2003 |
20339092 |
AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2
Hexner, EO,
Schwemmers, S,
Pahl, HL,
Wang, W
|
Blood |
2010 |
20876458 |
Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency
Kaur, G,
Dhanasekaran, DN,
Rao, AK,
Goldfinger, LE,
Mao, G,
Jalagadugula, G
|
Blood |
2010 |
21252065 |
Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1
Kaur, G,
Dhanasekaran, DN,
Rao, AK,
Mao, G,
Jalagadugula, G
|
Arterioscler. Thromb. Vasc. Biol. |
2011 |
18855616 |
Thrombospondin-1 in von Willebrand factor function
Hoylaerts, MF,
Bonnefoy, A
|
Curr Drug Targets |
2008 |
21129147 |
Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4
Rao, AK,
Singh, A,
Jalagadugula, G,
Mao, G,
Aneja, K
|
J. Thromb. Haemost. |
2011 |
18316480 |
Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity
Menendez, S,
Tempst, P,
Xiao, A,
Nimer, SD,
Allis, CD,
Erdjument-Bromage, H,
Zhao, X,
Pardanani, A,
Jankovic, V,
Zhang, J,
Dunne, R,
Gural, A,
Huang, G
|
Genes Dev. |
2008 |
21725049 |
Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia
Vainchenker, W,
Raslova, H,
Cordette-Lagarde, V,
Debili, N,
Ripoche, H,
Hilpert, M,
Antony-Debré, I,
Gonin, P,
Gilles, L,
Camara-Clayette, V,
Wagner-Ballon, O,
Bluteau, D,
Prchal, J,
Swierczek, S,
Favier, R,
James, C,
Robert, T
|
Blood |
2011 |
12576332 |
RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation
Elagib, KE,
Goldfarb, AN,
Mogass, M,
Racke, FK,
Khetawat, R,
Delehanty, LL
|
Blood |
2003 |
22777353 |
Histone arginine methylation keeps RUNX1 target genes in an intermediate state
Hussong, H,
Herglotz, J,
Kolodziej, S,
Grez, M,
Kuvardina, ON,
Kumar, A,
Lausen, J
|
Oncogene |
2013 |
2196092 |
Expression of platelet glycoprotein Ib by cultured human megakaryocytes: ultrastructural localization and biosynthesis
Cramer, E,
Nakazawa, M,
Vainchenker, W,
Guichard, J,
Kieffer, N,
Breton-Gorius, J,
Debili, N,
Titeux, M
|
Blood |
1990 |
16628190 |
Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome
Xu, G,
Terui, K,
Takahashi, Y,
Kitabayashi, I,
Kanezaki, R,
Ito, E,
Watanabe, S,
Toki, T
|
Leukemia |
2006 |
7787779 |
Platelet glycoprotein IIb gene expression as a model of megakaryocyte-specific expression
Poncz, M,
Block, KL
|
Stem Cells |
1995 |